Polymorphous lymphoproliferative disorder: a clinicopathological analysis
- 29 January 2010
- journal article
- research article
- Published by Springer Nature in Virchows Archiv
- Vol. 456 (3) , 269-276
Abstract
Lymphoproliferative disorder (LPD) with polymorphous composition of proliferation (polymorphous LPD), containing large lymphoid cells together with small lymphocytes, plasma cells, macrophages, and/or eosinophils, is found in individuals with immunodeficiency conditions. Clinicopathological findings in 19 cases of polymorphous LPD registered with the Osaka Lymphoma Study Group, Osaka, Japan, were analyzed; they represented 0.4% of the registered cases. In six cases, there was a history of rheumatoid arthritis; five of them had received immunosuppressive agents. There were no acquired immunodeficiency syndrome cases or organ transplant recipients. Southern blotting and/or polymerase chain reaction (PCR)-based clonality analysis revealed monoclonal B cell and T cell proliferation in eight and six cases (B- and T-LPD), respectively, and polyclonality in one. In B-LPD, there was polymorphous proliferation, containing large B-lymphoid cells, while medium-to-large T lymphoid cells with occasional eosinophilic infiltration were seen in T-LPD. Epstein–Barr virus (EBV) was detected in three of eight B-LPD, four of six T-LPD, and one of one polyclonal LPD. The prognosis was not favorable; the 3-year overall survival rate was 49.7 ± 17.3%. Thus, polymorphous LPD is relatively rare in Japan and is a heterogeneous disease with monoclonal proliferation of B or T cells; additionally, it is occasionally EBV-associated, and behaves as an aggressive lymphoma.Keywords
This publication has 16 references indexed in Scilit:
- First registry report: lung transplantation in JapanGeneral Thoracic and Cardiovascular Surgery, 2008
- Pathophysiological links between rheumatoid arthritis and the Epstein–Barr virus: An updateJoint Bone Spine, 2007
- Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.2006
- Posttransplant Lymphoproliferative Disease: A Series of 23 CasesTransplantation Proceedings, 2006
- Reactivation of Latent Epstein-Barr Virus by Methotrexate: A Potential Contributor to Methotrexate-Associated LymphomasJNCI: Journal of the National Cancer Institute, 2004
- Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936Leukemia, 2003
- Culture, brain death, and transplantationProgress in Transplantation, 2003
- Post-transplant lymphoproliferative disordersPathology and Oncology Research, 1997
- Hodgkin's Disease and Lymphoproliferations Resembling Hodgkin's Disease in Patients Receiving Long-Term Low-Dose Methotrexate TherapyAmerican Journal of Surgical Pathology, 1996
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993